However, in other cancer types, such as liver carcinoma and glioblastoma, GM-CSF is involved in the induction of MDSCs [149, 150], but during immunotherapy in neuroblastoma, GM-CSF appears to activate neutrophils instead. This evidence concerns the gene CSF2 and hepatocellular carcinoma.